Login Register Cart 0
Generic placeholder image

Current Computer-Aided Drug Design

Editor-in-Chief

ISSN (Print): 1573-4099
ISSN (Online): 1875-6697

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Combinatorial Design of Molecule using Activity-Linked Substructural Topological Information as Applied to Antitubercular Compounds

Author(s): Chandan Raychaudhury, Md. Imbesat Hassan Rizvi and Debnath Pal*

Volume 15, Issue 1, 2019

Page: [67 - 81] Pages: 15

DOI: 10.2174/1573409914666180509152711

Price: $65

Abstract

Background: Generating a large number of compounds using combinatorial methods increases the possibility of finding novel bioactive compounds. Although some combinatorial structure generation algorithms are available, any method for generating structures from activity-linked substructural topological information is not yet reported.

Objective: To develop a method using graph-theoretical techniques for generating structures of antitubercular compounds combinatorially from activity-linked substructural topological information, predict activity and prioritize and screen potential drug candidates.

Methods: Activity related vertices are identified from datasets composed of both active and inactive or, differently active compounds and structures are generated combinatorially using the topological distance distribution associated with those vertices. Biological activities are predicted using topological distance based vertex indices and a rule based method. Generated structures are prioritized using a newly defined Molecular Priority Score (MPS).

Results: Studies considering a series of Acid Alkyl Ester (AAE) compounds and three known antitubercular drugs show that active compounds can be generated from substructural information of other active compounds for all these classes of compounds. Activity predictions show high level of success rate and a number of highly active AAE compounds produced high MPS score indicating that MPS score may help prioritize and screen potential drug molecules. A possible relation of this work with scaffold hopping and inverse Quantitative Structure-Activity Relationship (iQSAR) problem has also been discussed.

Conclusion: The proposed method seems to hold promise for discovering novel therapeutic candidates for combating Tuberculosis and may be useful for discovering novel drug molecules for the treatment of other diseases as well.

Keywords: Combinatorial drug design, activity-linked substructure, graph theory, topological vertex index, rule based method, activity prediction, prioritization, screening.

« Previous Next »
Graphical Abstract

[1]
Ruddigkeit, L.; Van Deursen, R.; Blum, L.C.; Reymond, J-L. Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. J. Chem. Inf. Model., 2012, 52, 2864-2875.
[2]
Hansch, C.; Sammes, P.G.; Taylor, J.B.; Ramsden, C., Eds.; Comprehensive Medicinal Chemistry: Quantitative Drug Design.Vol. 4; Pergamon Press: New York, 1990.
[3]
Kier, L.B.; Hall, L.H. Molecular Connectivity in Structure-Activity Analysis; Research Studies: Chichester, 1986.
[4]
Basak, S.C.; Restrepo, G.; Villaveces, J.L., Eds.; Advances in Mathematical Chemistry and Applications.d.; Vol 1-2 (Revised Edition);
[5]
Kitchen, D.B.; Decornez, H.; Furr, J.R.; Bajorath, J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat. Rev. Drug Discov., 2004, 3, 935-949.
[6]
Cramer, R.D. Topomer CoMFA: A design methodology for rapid lead optimization. J. Med. Chem., 2003, 46, 374-389.
[7]
Sun, H.; Tawa, G.; Wallqvist, A. Classification of scaffold-hopping approaches. Drug Discov. Today, 2012, 17, 310-324.
[8]
Prathipati, P.; Ma, N.L.; Keller, T.H. Global bayesian models for the prioritization of antitubercular agents. J. Chem. Inf. Model., 2008, 48, 2362-2370.
[9]
Tanwar, J.; Das, S.; Fatima, Z.; Hameed, S. Multidrug resistance: An emerging crisis.Interdisciplinary Perspectives on Infectious Diseases 2014,
[http://dx.doi.org/10.1155/2014/541340]
[10]
Gálvez, J.; García-Domenech, R. On the contribution of molecular topology to drug design and discovery. Curr. Comput.-. Aided Drug Des., 2010, 6, 252-268.
[11]
Gugisch, R.; Kerber, A.; Kohnert, A.; Laue, R.; Meringer, M.; Rücker, C.; Wassermann, A. MOLGEN 5.0, A molecular structure generator. Adv. Math. Chem. App., 2014, 1, 113-138.
[12]
Faulon, J-L.; Bender, A. Handbook of chemoinformatics algorithms; CRC press: Boca Raton, 2010.
[13]
Wong, W.W.; Burkowski, F.J. A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem. J. Cheminform., 2009, 1, 4.
[14]
Beyer, T.; Hedetniemi, S.M. Constant time generation of rooted trees. SIAM Journal on Computing, 1980, 9, 706-712.
[15]
Gibbs, N.E. A cycle generation algorithm for finite undirected linear graphs. J. A. C. M., 1969, 16, 564-568.
[16]
Klopman, G.; Raychaudhury, C. Vertex indexes of molecular graphs in structure-activity relationships: A study of the convulsant-anticonvulsant activity of barbiturates and the carcinogenicity of unsubstituted polycyclic aromatic hydrocarbons. J. Chem. Inf. Comput. Sci., 1990, 30, 12-19.
[17]
Raychaudhury, C.; Pal, D. Use of vertex index in structure-activity analysis and design of molecules. Curr. Comput.-. Aided Drug Des., 2012, 8, 128-134.
[18]
Raychaudhury, C.; Kandel, D.D.; Pal, D. Role of vertex index in substructure identification and activity prediction: A study on antitubercular activity of a series of acid alkyl ester derivatives. Croat. Chem. Acta,2014, 87, 39-47; (b) Pieroni, M.: Lilienkampf, A.; Wan, B.; Wang, Y.; Franzblau, S.G.; Kozikowski, A.P. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. J. Med. Chem., 2009, 52, 6287-6296.
[19]
Günther, G. Multidrug-resistant and extensively drug-resistant tuberculosis: A review of current concepts and future challenges. Clin. Med. , 2014, 14, 279-285.
[20]
Raychaudhury, C.; Klopman, G. New Vertex Indices and their Applications in Evaluating Antileukemic Activity of 9‐Anilinoacridines and the Activity of 2′, 3′‐Dideoxy‐Nuclosides Against HIV. Bull. Soc. Chim. Belg., 1990, 99, 255-264.
[21]
Raychaudhury, C.; Dey, I.; Bag, P.; Biswas, G.; Das, B.; Roy, P.; Banerjee, A. Use of a rule based graph-theoretical system in evaluating the activity of a class of nucleoside analogues against human immunodeficiency virus. Arzneim.-Forsch. Drug Res., 1993, 43, 1122-1125.
[22]
Kandel, D.D.; Raychaudhury, C.; Pal, D. Two new atom centered fragment descriptors and scoring function enhance classification of antibacterial activity. J. Mol. Model., 2014, 20, 2164.
[23]
Moss, G. Extension and revision of the von Baeyer system for naming polycyclic compounds (including bicyclic compounds). Pure Appl. Chem., 1999, 71, 513-529.
[24]
Weininger, D.; Weininger, A.; Weininger, J.L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci., 1989, 29, 97-101.
[25]
Zumla, A.; Nahid, P.; Cole, S.T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov., 2013, 12, 388-404.
[26]
Timmins, G.S.; Deretic, V. Mechanisms of action of isoniazid. Mol. Microbiol., 2006, 62, 1220-1227.
[27]
DrugBank https://www.drugbank.ca/drugs/DB00339 (Accessed on October 12, 2017)

Rights & Permissions Print Cite
Article Metrics
33
4
1
© 2024 Bentham Science Publishers | Privacy Policy